Cargando…
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive disease, with few available treatment options. Identification of novel prognostic and predictive biomarkers is a priority. In MPM patients, BRCA-associated protein 1 (BAP1) alterations are detected in about 60% of cases and miR-31 see...
Autores principales: | Murrone, Albero, Cantini, Luca, Pecci, Federica, Cognigni, Valeria, Copparoni, Cecilia, Rinaldi, Silvia, Fiordoliva, Ilaria, Monaco, Federica, Rubini, Corrado, Barbisan, Francesca, Cimadamore, Alessia, Giampieri, Riccardo, Bianchi, Francesca, Tomasetti, Marco, Amati, Monica, Santarelli, Lory, Berardi, Rossana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575852/ https://www.ncbi.nlm.nih.gov/pubmed/34795923 http://dx.doi.org/10.21037/jtd-21-555 |
Ejemplares similares
-
ATG5 as biomarker for early detection of malignant mesothelioma
por: Tomasetti, Marco, et al.
Publicado: (2023) -
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study
por: Liguori, Carolina, et al.
Publicado: (2023) -
Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
por: Tomasetti, Marco, et al.
Publicado: (2010) -
Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
por: Tomasetti, Marco, et al.
Publicado: (2019) -
Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
por: Giampieri, Riccardo, et al.
Publicado: (2020)